Dimensional Fund Advisors
OVID icon

Dimensional Fund Advisors’s Ovid Therapeutics OVID Stock Holding History

Dimensional Fund Advisors’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,719
Closed -$3.34K – 3313
2025
Q1 		$3.34K Sell
10,719
-82,252
-88% -$50.6K ﹤0.01% 3320
2024
Q4 		$86.9K Sell
92,971
-11,040
-11% -$12.4K ﹤0.01% 3253
2024
Q3 		$123K Sell
104,011
-170,971
-62% -$179K ﹤0.01% 3223
2024
Q2 		$211K Sell
274,982
-67,187
-20% -$187K ﹤0.01% 3154
2024
Q1 		$1.04M Buy
342,169
+98,874
+41% +$331K ﹤0.01% 2918
2023
Q4 		$784K Buy
243,295
+100,437
+70% +$343K ﹤0.01% 2974
2023
Q3 		$549K Buy
142,858
+20
+0% +$72 ﹤0.01% 3034
2023
Q2 		$469K Hold
142,838
– – ﹤0.01% 3075
2023
Q1 		$369K Buy
142,838
+107,134
+300% +$254K ﹤0.01% 3087
2022
Q4 		$67 Sell
35,704
-6,016
-14% -$10.2K ﹤0.01% 3369
2022
Q3 		$77K Buy
+41,720
New +$87.3K ﹤0.01% 3364
2022
Q2 		– Sell
-19,564
Closed -$61K – 3513
2022
Q1 		$61K Hold
19,564
– – ﹤0.01% 3444
2021
Q4 		$63K Buy
+19,564
New +$67K ﹤0.01% 3471
2020
Q4 		– Sell
-52,819
Closed -$303K – 3358
2020
Q3 		$303K Hold
52,819
– – ﹤0.01% 3154
2020
Q2 		$389K Sell
52,819
-8,975
-15% -$42K ﹤0.01% 3122
2020
Q1 		$184K Sell
61,794
-28,907
-32% -$97.4K ﹤0.01% 3213
2019
Q4 		$376K Hold
90,701
– – ﹤0.01% 3178
2019
Q3 		$294K Hold
90,701
– – ﹤0.01% 3229
2019
Q2 		$168K Hold
90,701
– – ﹤0.01% 3345
2019
Q1 		$161K Buy
90,701
+3,444
+4% +$8.61K ﹤0.01% 3334
2018
Q4 		$211K Buy
87,257
+8,995
+11% +$41K ﹤0.01% 3277
2018
Q3 		$444K Buy
+78,262
New +$593K ﹤0.01% 3199

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Dimensional Fund Advisors's OVID Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Ovid Therapeutics (OVID) in Q2 2025, closing a stake of 10,719 shares — an estimated $3.34K sold.

Dimensional Fund Advisors first reported a position in OVID in Q3 2018 and held it in 22 quarters. The position peaked at $1.04M in Q1 2024. 71 funds tracked by Wall St. Rank hold OVID as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Ovid Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 10,719 Ovid Therapeutics shares in Q2 2025, an estimated $3.34K.
  • Dimensional Fund Advisors first reported a position in Ovid Therapeutics in Q3 2018 and held it in 22 quarters.
  • Dimensional Fund Advisors's Ovid Therapeutics position peaked at $1.04M in Q1 2024.
  • 71 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.